Effects of magnetic induction hyperthermia and radiotherapy alone or combined on a murine 4T1 metastatic breast cancer model

被引:22
作者
Wang, Hui [2 ,3 ]
Li, Xiao [1 ]
Xi, Xuping [3 ]
Hu, Bingqiang [3 ]
Zhao, Lingyun [1 ]
Liao, Yuping [2 ]
Tang, Jintian [1 ]
机构
[1] Tsinghua Univ, Dept Engn Phys, Key Lab Particle & Radiat Imaging, Minist Educ, Beijing 100084, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Dept Radiat Oncol, Changsha, Hunan, Peoples R China
[3] Hunan Prov Tumour Hosp, Dept Radiat Oncol, Changsha, Hunan, Peoples R China
关键词
breast cancer; magnetic induction hyperthermia; metastasis; radiotherapy; survival; RADIATION-THERAPY; CELLULAR-IMMUNITY; CELLS; MICE; APOPTOSIS; TUMOR; TRIBROMOETHANOL; REIRRADIATION; EXPRESSION;
D O I
10.3109/02656736.2011.583618
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to explore the effects of MIH and radiotherapy alone or combined on metastatic breast cancer and the underlying mechanisms. Materials and methods: A murine 4T1 metastatic breast cancer model was established and randomly assigned into four treatment groups: C (control), R (radiotherapy), MIH, and MIH + R. Tumour volume, lung metastasis, the expression of Bax and MMP-9, T cell subsets, serum cytokine levels, and mouse survival were evaluated. Results: Group MIH + R showed significantly reduced tumour volume, lung metastasis, improved survival and increased Bax expression compared to group R or MIH (P < 0.05). MMP-9 expression in the primary tumour tissue was significantly increased in group R compared to the other groups (P < 0.05), which could be brought down by combined MIH treatment. Group MIH + R showed significantly higher CD4(+) T cell percentage as well as CD4(+)/CD8(+) cell ratio than group R (P < 0.05). Group MIH + R showed significantly higher serum levels of TNF-alpha, IFN-gamma and IL-2 than group R (P < 0.05). Conclusions: MIH not only promotes the tumour-cell killing effect of radiotherapy through Bax-mediated cell death, but also improves cellular immunity in mice under radiotherapy and decreases the potential of radiotherapy to enhance MMP-9 expression, which leads to significant improvement in lung metastasis and overall survival of mice under combined treatment of MIH and R. This study is the first to have explored the effect of combined hyperthermia and radiotherapy on tumour metastasis and the underlying mechanisms. It provides insights into the application of MIH as an adjuvant to radiotherapy for metastatic breast cancer.
引用
收藏
页码:563 / 572
页数:10
相关论文
共 38 条
[1]  
ASLAKSON CJ, 1992, CANCER RES, V52, P1399
[2]  
Bertone V, 1997, ANTICANCER RES, V17, P4713
[3]  
Camphausen K, 2001, CANCER RES, V61, P2207
[4]  
CAVALIER.R, 1967, CANCER-AM CANCER SOC, V20, P1351, DOI 10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO
[5]  
2-#
[6]   The treatment of malignancy by hyperthermia [J].
Christophi, C ;
Winkworth, A ;
Muralihdaran, V ;
Evans, P .
SURGICAL ONCOLOGY-OXFORD, 1998, 7 (1-2) :83-90
[7]   Status of clinical hyperthermia [J].
Dahl, O ;
Dalene, R ;
Schem, BC ;
Mella, O .
ACTA ONCOLOGICA, 1999, 38 (07) :863-873
[8]   ARRHENIUS RELATIONSHIPS FROM THE MOLECULE AND CELL TO THE CLINIC [J].
DEWEY, WC .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1994, 10 (04) :457-483
[9]   INDUCTION OF APOPTOTIC CELL-DNA FRAGMENTATION IN HUMAN-CELLS AFTER TREATMENT WITH HYPERTHERMIA [J].
FAIRBAIRN, JJ ;
KHAN, MW ;
WARD, KJ ;
LOVERIDGE, BW ;
FAIRBAIRN, DW ;
ONEILL, KL .
CANCER LETTERS, 1995, 89 (02) :183-188
[10]  
FUMA N, 2001, BRIT J RADIOL, V74, P709